Abstract
A modification of fluconazole formulation in the VITEK2 AST-YS08 card revoked the fluconazole–Candida glabrata combination. An evaluation of AST-YS08 following C. glabrata to C. albicans adjustment within VITEK2 software revealed higher fluconazole MICs compared to AST-YS07 and E-test, with major discrepancies. This mandates an alternative approach to fluconazole–C. glabrata susceptibility testing.
Original language | English |
---|---|
Article number | 114896 |
Journal | Diagnostic Microbiology and Infectious Disease |
Volume | 96 |
Issue number | 2 |
DOIs | |
State | Published - Feb 2020 |
Externally published | Yes |
Keywords
- AST-YS08 card
- Candida glabrata
- Susceptibility testing
- VITEK2